Massachusetts Institute of Technology Massachusetts Institute of Technology
Department of Chemical Engineering
Myerson Group
Home
Research
Members
Publications
Seminars
Links
Safety & Training
Job Openings
For Members
Contact Us
 

The Myerson Group

Back to Members List

Dr. Vibha Puri

Postdoctoral Associate

Department of Chemical Engineering
Massachusetts Institute of Technology
Room: E19-534
77 Massachusetts Ave.
Cambridge, MA 02139

Phone: (617) 324-4401
E-mail: puriv@mit.edu

Education:

  1. Ph.D. Pharmaceutics – National Institute of Pharmaceutical Education and Research (NIPER), Punjab, India - November, 2011
  2. M. Pharm. Pharmaceutical Technology (Formulations) - National Institute of Pharmaceutical Education and Research (NIPER), Punjab, India – December, 2001

Research summary:

Formulation scientist with experience in pharmaceutical material science (preformulation, API solid-state modification) and formulation development. My PhD work focused on ‘Pharmaceutical product development of a model amorphous solid dispersion’. Some key investigated areas were amorphous solid dispersion (ASD) phase behavior characterization using gamut of thermal/crystallographic/spectroscopic techniques, preformulation profiling, understanding of solid-liquid interfacial interactions and dissolution behavior, surface molecular mobility and surface stabilization of ASDs, followed by development of ‘barrier coated ASD layered particles’ as a tailor-made formulation strategy.

I hold industrial R&D experience in pharmaceutical product (oral solid & liquids) development, encompassing activities from conceptualization of formulation strategy to technology transfer at manufacturing locations and cross-functional activities for drug product filing.

My current research area is development of electrospinning and thin film technologies as downstream continuous manufacturing platforms at the Novartis-MIT Center for Continuous Manufacturing. I also provide general pharmaceutical science support for all downstream processes that are considering oral solid dosage forms as the end goal.

Keywords:

Preformulation, formulation development, drug delivery, biopharmaceutics, API solid-state modification, amorphous drug delivery, polymorphism, material characterization, interfacial interactions, formulation process technologies


The Myerson Group, 77 Massachusetts Ave, Rm 66-568, Cambridge, MA 02139 | Tel: 617.452.3790 | updated: May 15, 2013